SUIC Beneway Welcomes Industry Leader Paul Fetscher as Director - President of Great American Brokerage, Esteemed Speaker, Columnist, and Chair of National Conferences, More Top Talent Joins to Accelerate Beneway's IPO Process

Stock Information for Harpoon Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Harpoon Therapeutics Inc.

SUIC's I.Hart Partners With the World's Largest Channel and Franchisor - Shaxian Snacks Group to Promote Both Shaxian and I.Hart's Taiwanese Products to Its 100,000 Store Channels Globally
SUIC's I.Hart Secures Key Distribution Partnerships and Signed Certified JV to Expands to Serve NYC Agencies, Airports, and Schools with Diverse Cuisine and Full Restaurant Supply Line
Former Paraguay Vice President Applauds Taiwan's Culinary Excellence at SUIC Partner iHArt's Lifekitchen and Central Kitchen, Eyes Brand Expansion to Paraguay and Global Alliances as US Industry Leaders Push for Nationwide Growth
SUIC's Taiwan I.Hart Group Establishes Franchise Headquarters, Expands Wine Brand Retail, Scales Up Operations & Factory Production with New Equipment and Food Product Lines, Growing Distribution Channels and Sales Teams Across All 50 States
SUIC's IHart Secures Major Contracts with Taiwan French Food Group and Healthcare Giants. Expands Global Reach as US Subsidiary Gets NYC Certification to Deliver Diverse Cuisines and Automated Product Lines in the US
SUIC's I.Hart Group Opens Two Monga Stores in China, Aims for 100 in a Year and Organizes Team Targets Tri-State Area for Major U.S. Expansion
SUIC Worldwide Holdings CEO Hank Wang Outlines Strategic Vision and Growth Milestones in Shareholder Letter
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Hank Wang, CEO of SUIC Worldwide Holdings Ltd.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.